Skip to main content

Displaying 341 - 350 of 350

Fresenius AG, and Fresenius USA, Inc., In the Matter of

Order settles charges that the acquisition of National Medical Care, Inc. would combine two significant producers of HD concentrate used in hemodialysis treatment. The order requires the divestiture of the Lewisberry, Pennsylvania hemodialysis concentrate plant to Di-Chem, Inc. or other Commission-approved buyer.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
9610053
Docket Number
C-3689
Jul20

Open Commission Meeting - July 20, 2023

-
Business Before the Commission: Statement Withdrawing Prior PBM Advocacy and Staff Presentation on Military Consumer Protection Efforts
Competition Matters

Monitors: Expert eyes and ears in Commission orders

Date
The ability to appoint a monitor is an important tool in building a successful merger remedy. The boilerplate-style language FTC uses in merger orders when appointing a monitor belies the unique and...
Basic page

Pharmaceutical Agreement Filings

The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 requires that brand-name drug manufacturers and generic drug applicants file certain agreements with the FTC and the...